KN
Highly rated in
3
conditions
Highly rated in
3
conditions
Check Dr. Kushal Naha's experience treating your condition:
About Dr. Kushal Naha

Kushal Naha is a Hematologist Oncology expert in Columbia, Missouri. Naha has been practicing medicine for over 16 years and is highly rated in 3 conditions, according to our data. His top areas of expertise are Congenital Nonhemolytic Jaundice, Vitamin B12 Deficiency, Vitamin B12 Deficiency Anemia, and Rotor Syndrome. He is licensed to treat patients in Missouri. Naha is currently accepting new patients.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Kushal Naha it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Kushal Naha accepts the following insurance:

  •  Ambetter
  •  Medica
  •  Health Alliance
Locations
1 Hospital Dr, Columbia, MO 65212
Background & Education
Graduate Institution
Other, 2006
Specialties
Hematology Oncology
Licenses
Internal Medicine in MO
Hospital Affiliations
University Hospital
Ellis Fischel Cancer Center
Boone Hospital Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs Maintenance Avelumab After First-Line Platinum-Based Chemotherapy in Patients With Metastatic Urothelial Cancer
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Phase II Randomized Trial of Atezolizumab Versus Atezolizumab and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (ART)
CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors